NextPharma

NextPharma is a leading European pharmaceutical Contract Development and Manufacturing Organization (CDMO) with a current footprint spanning five sites in Germany, two in France one in Finland, one in Normway and one in Scotland, and with healthcare logistics services in the DACH region. NextPharma supplies products globally, with eight of its nine sites FDA-approved. With expertise in solids, semi solids and non-sterile and sterile liquids, the company provides services from pharmaceutical development, clinical supplies, scale-up and process validation through to commercial manufacturing for a large range of dosage forms including tablets, capsules, granules, powders, pellets, gels, creams, liquid-filled capsules, softgels, sprays and syrups. Additionally, it provides a wide range of packaging solutions including blow-fill-seal, blisters, bottles, sachets, stick packs and tubes. NextPharma’s expertise and centers of excellence enable it to provide a unique service offering in certain very specific specialized areas such as hormonal solids and semi-solids, cephalosporins, penicillins, narcotics, modified release products, lipid-based formulations (including hormonal and high potent products), as well as paediatric medicinal products. For more information, please visit www.nextpharma.com.